<DOC>
	<DOC>NCT02221362</DOC>
	<brief_summary>Study 701-901, a multicenter, multinational, longitudinal, non-interventional observational study in subjects, at least 18 years old, diagnosed with late-onset Pompe disease prospectively collects data to understand clinical progression in terms of respiratory function, symptomology, genotype, biochemistry, endurance and selected subject-reported measures for 24 weeks followed by a 240 week additional observation period for up to 100 subjects.</brief_summary>
	<brief_title>A Prospective, Noninterventional, Observational Study of Late-Onset Pompe Disease</brief_title>
	<detailed_description />
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<criteria>Willing and able to provide written informed consent after the nature of the study has been explained and prior to any studyrelated procedure Diagnosed with lateonset Pompe disease based on current or previous genomic testing and/or endogenous GAA activity At least 18 years of age at study entry Willing and able to comply with all study procedures Requires noninvasive ventilatory support while awake and in the upright position Concurrent disease, medical condition, or extenuating circumstance that, in the opinion of the investigator, might compromise study completion or data collection Unable to perform baseline efficacy assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>